Skip to main content
Premium Trial:

Request an Annual Quote

South Korean Firm Files IP Suit Against Life Technologies

NEW YORK (GenomeWeb News) – South Korean firm Boram Pharm has filed a patent infringement suit in the US against Life Technologies alleging infringement of a patent covering technology for producing recombinant viruses.

The suit was filed last week in the US District Court for the District of Delaware. Boram claims that Life Technologies is infringing US Patent No. 7,319,001, titled "High throughput system for producing recombinant viruses using site-specific recombination." The patent was issued on Jan. 15, 2008 to Neurogenex, which is now owned by Boram.

In the suit, Boarm claims that Life Technologies' BaculoDirect Baculovirus Expression System infringes the patent.

It has asked the court to declare that Life Technologies has willfully infringed the patent, enjoin Life Tech from further alleged infringement, award compensatory damages, and treble the damages amount.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.